STOCK TITAN

Insider Justin Klee plans AMLX (NASDAQ: AMLX) stock sale under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AMLX filed a Rule 144 notice for a planned insider stock sale. The filing covers the proposed sale of 1,995 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $26,972.40 as of the filing details.

The shares to be sold were acquired on January 16, 2026 via an exercise of stock options paid in cash on the same date. The notice also lists prior sales of the issuer’s common stock during the past three months for the account of Justin Klee, including 136,193 shares sold on January 15, 2026 for gross proceeds of $1,849,860.26 and 7,715 shares sold on January 6, 2026 for gross proceeds of $85,589.44.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the AMLX Rule 144 filing disclose?

The filing discloses a planned sale of 1,995 shares of the issuer’s common stock on NASDAQ under Rule 144, with an aggregate market value of $26,972.40.

Who is associated with the recent AMLX stock sales?

The filing shows sales for the account of Justin Klee, including pre-set sales noted in the section listing securities sold during the past three months.

How many AMLX shares are planned to be sold under this notice?

The notice covers 1,995 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.

How were the AMLX shares being sold acquired?

The 1,995 shares to be sold were acquired on January 16, 2026 through the exercise of stock options from the issuer, with the purchase price paid in cash.

What AMLX stock sales occurred in the past three months for this insider?

The filing lists 136,193 shares of common stock sold on January 15, 2026 for $1,849,860.26 and 7,715 shares sold on January 6, 2026 for $85,589.44.

On which exchange will the AMLX shares be sold?

The notice indicates the common stock is to be sold on NASDAQ.
Amylyx Pharmaceuticals

NASDAQ:AMLX

View AMLX Stock Overview

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.59B
93.74M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CAMBRIDGE